About Us
The Mischer Neuroscience Institute is built on a foundation of long-term collaboration between Memorial Hermann-Texas Medical Center and The University of Texas Medical School at Houston. The Institute brings together a team of world-class clinicians, researchers and educators whose insights and research findings are transforming the field of neuroscience. Patients come to the Institute from around the world for treatment of rare and common diseases of the brain and spinal cord.
Part of the 11-hospital Memorial Hermann System, the Mischer Neuroscience Institute is the largest and most comprehensive neuroscience program in Texas. We currently perform more neurosurgical procedures than any other hospital system in Houston and are nationally recognized for leading-edge medicine. We are consistently ranked among quality benchmarking organizations as a leader in clinical quality and patient safety. The Institute was the first center in Texas and one of only a few institutions in the country to fully integrate neurology, neurosurgery, neuroradiology and neurorehabilitation through comprehensive, specialized treatment centers and close collaboration between all involved disciplines.
More than 2,000 procedures are performed in our surgical neuroscience suites annually. Among them are innovative techniques that were once unimaginable: implantations of vagal nerve stimulators that allow patients with epilepsy to lead productive lives, resections of arteriovenous malformations that prevent life-threatening brain hemorrhage, and Gamma Knife radiosurgery that makes treatment of brain tumors safe, quick, effective and painless.
At the Mischer Neuroscience Institute, we continually push the envelope in neurological and neurosurgical care in ways that are appropriate for the patients we treat. The Institute was the first center in Houston to test and prove the efficacy of three disparate treatments for stroke prevention: carotid surgery; administration of antiplatelet drugs, including aspirin; and patent foramen ovale closure, the first in Houston and one of the first in the United States to test the clot-dissolving drug tPA for acute stroke, the first center to conduct a national, multi-center trial for hypothermia in head injury and the first to bring the clinical magnetoencephaolgraphy (MEG) sensor to Houston - which remains the only MEG in clinical use throughout Texas, Louisiana, Arkansas and Oklahoma.
Mischer Neuroscience Institute
6411 Fannin
Houston, TX 77030